Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Busulfan, Cyclophosphamide, Antithymocyte Globulin
(D00287)		2件: Busulfan,
Cyclophosphamide		3件: Busulfan ,
Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--2件: 19, 20 💬
2Busulfan, Cyclophosphamide, ATG
(D00287)		2件: Busulfan,
Cyclophosphamide		3件: Busulfan ,
Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 19 💬
3Busulfan, Cyclophosphamide, ATG, GCSF
(D00287)		2件: Busulfan,
Cyclophosphamide		3件: Busulfan ,
Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--2件: 65, 284 💬
4Busulfan, Cyclophosphamide, Thymoglobulin, Fludarabine (Conditioning regimen)
(D00287)		4件: Antithymocyte immunoglobulin (rabbit),
Busulfan,
Cyclophosphamide,
Fludarabine		4件: Busulfan ,
Cyclophosphamide (D00287),
Cyclophosphamide ,
Fludarabine 💬 		1件: RRM1 💬 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 326 💬
5Busulfan, fludarabine, & cyclophosphamide with immunosuppression with ATG and cyclosporine.
(D00287)		4件: Busulfan,
Cyclophosphamide,
Cyclosporine,
Fludarabine		5件: Cyclosporine ,
Busulfan ,
Cyclophosphamide (D00287),
Cyclophosphamide ,
Fludarabine 💬 		6件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2,
RRM1 💬 		39件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Glutathione metabolism, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Nucleotide metabolism, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Pyrimidine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 60, 285 💬
6Campath, Fludarabine, Cyclophosphamide
(D00287)		2件: Cyclophosphamide,
Fludarabine		3件: Cyclophosphamide (D00287),
Cyclophosphamide ,
Fludarabine 💬 		1件: RRM1 💬 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 65, 284 💬
7Cyclophosphamide
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331 💬
8Cyclophosphamide (CY)
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 60 💬
9Cyclophosphamide (CY) (Plan 1)
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--2件: 60, 285 💬
10Cyclophosphamide (CY) (Plan 2)
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--2件: 60, 285 💬
11Cyclophosphamide (Cytoxan)
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 65 💬
12Cyclophosphamide (drug)
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 13 💬
13Cyclophosphamide + pred
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 283 💬
14Cyclophosphamide 100mg
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 60 💬
15Cyclophosphamide 150mg
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 60 💬
16Cyclophosphamide 30
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--3件: 65, 285, 326 💬
17Cyclophosphamide 40
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--3件: 65, 285, 326 💬
18Cyclophosphamide 50mg
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 60 💬
19Cyclophosphamide 50Mg Oral Tablet
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 162 💬
20Cyclophosphamide and ATG
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 13 💬
21Cyclophosphamide and fludarabine
(D00287)		2件: Cyclophosphamide,
Fludarabine		3件: Cyclophosphamide (D00287),
Cyclophosphamide ,
Fludarabine 💬 		1件: RRM1 💬 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 11, 13 💬
22Cyclophosphamide and steroids
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 222 💬
23Cyclophosphamide Dose Level 1
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--2件: 65, 284 💬
24Cyclophosphamide Dose Level 2
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--2件: 65, 284 💬
25Cyclophosphamide Dose Level 3
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--2件: 65, 284 💬
26Cyclophosphamide Dose Level 4
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--2件: 65, 284 💬
27Cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids
(D00287)		3件: Azathioprine,
Cyclophosphamide,
Methotrexate		4件: Methotrexate ,
Azathioprine ,
Cyclophosphamide (D00287),
Cyclophosphamide 💬 		2件: DHFR,
DHFR2 💬 		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 44 💬
28Cyclophosphamide Injection 1g
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--3件: 50, 51, 52 💬
29CYCLOPHOSPHAMIDE MONOHYDRATE
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--4件: 13, 60, 96, 256 💬
30Cyclophosphamide post transplant
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 65 💬
31Cyclophosphamide(CTX)
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 224 💬
32Cyclophosphamide, Azathioprine,prednisone,methylprednisolone
(D00287)		4件: Azathioprine,
Cyclophosphamide,
Methylprednisolone,
Prednisone		5件: Azathioprine ,
Cyclophosphamide (D00287),
Methylprednisolone ,
Prednisone ,
Cyclophosphamide 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬3件: 42, 43, 45 💬
33Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen
(D00287)		3件: Bortezomib,
Cyclophosphamide,
Dexamethasone		4件: Cyclophosphamide (D00287),
Dexamethasone ,
Bortezomib ,
Cyclophosphamide 💬 		2件: NR3C1,
PSMB5 💬 		9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28 💬
34Cyclophosphamide, Bortezomib, dexamethasone
(D00287)		3件: Bortezomib,
Cyclophosphamide,
Dexamethasone		4件: Cyclophosphamide (D00287),
Dexamethasone ,
Bortezomib ,
Cyclophosphamide 💬 		2件: NR3C1,
PSMB5 💬 		9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28 💬
35Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab
(D00287)		4件: Bortezomib,
Cyclophosphamide,
Daratumumab,
Dexamethasone		5件: Cyclophosphamide (D00287),
Dexamethasone ,
Bortezomib ,
Cyclophosphamide ,
Daratumumab 💬 		3件: CD38,
NR3C1,
PSMB5 💬 		16件: Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬1件: 28 💬
36Cyclophosphamide, fludarabine , thymoglobulin
(D00287)		3件: Antithymocyte immunoglobulin (rabbit),
Cyclophosphamide,
Fludarabine		3件: Cyclophosphamide (D00287),
Cyclophosphamide ,
Fludarabine 💬 		1件: RRM1 💬 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 60 💬
37Cyclophosphamide, Fludarabine, Rabbit ATG
(D00287)		4件: Antithymocyte immunoglobulin (rabbit),
Cyclophosphamide,
Fludarabine,
Rabbit		3件: Cyclophosphamide (D00287),
Cyclophosphamide ,
Fludarabine 💬 		1件: RRM1 💬 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 60 💬
38Cyclophosphamide, Fludarabine, Thymoglobulin
(D00287)		3件: Antithymocyte immunoglobulin (rabbit),
Cyclophosphamide,
Fludarabine		3件: Cyclophosphamide (D00287),
Cyclophosphamide ,
Fludarabine 💬 		1件: RRM1 💬 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 60 💬
39Cyclophosphamide,Campath IH and TBI
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 60 💬
40Cyclophosphamide,cyclosporine A
(D00287)		2件: Cyclophosphamide,
Cyclosporine		3件: Cyclosporine ,
Cyclophosphamide (D00287),
Cyclophosphamide 💬 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 60 💬
41Cyclophosphamide-prednisone-azathioprine
(D00287)		3件: Azathioprine,
Cyclophosphamide,
Prednisone		4件: Azathioprine ,
Cyclophosphamide (D00287),
Prednisone ,
Cyclophosphamide 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 49 💬
42Cyclophosphamide/ATG
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 13 💬
43Cyclophosphamide/Glatiramer acetate
(D00287)		3件: Acetate,
Cyclophosphamide,
Glatiramer		2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 13 💬
44Cyclophosphamide/Rituximab
(D00287)		2件: Cyclophosphamide,
Rituximab		3件: Cyclophosphamide (D00287),
Rituximab ,
Cyclophosphamide 💬 		1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
45Doxorubicin, methotrexate, cyclophosphamide, L-asparaginase
(D00287)		4件: Asparaginase Escherichia coli,
Cyclophosphamide,
Doxorubicin,
Methotrexate		4件: Methotrexate ,
Cyclophosphamide (D00287),
Doxorubicin ,
Cyclophosphamide 💬 		4件: DHFR,
DHFR2,
TOP2A,
TOP2B 💬 		6件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate, Platinum drug resistance 💬1件: 65 💬
46Fludarabine, Cyclophosphamide
(D00287)		2件: Cyclophosphamide,
Fludarabine		3件: Cyclophosphamide (D00287),
Cyclophosphamide ,
Fludarabine 💬 		1件: RRM1 💬 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 60 💬
47Glucocorticoid combined with cyclophosphamide induction + maintenance
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 222 💬
48Haploidentical HSCT using TBI free regimen, ''ATG'' with ''Post transplant cyclophosphamide''
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 60 💬
49High-dose Cyclophosphamide
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 96 💬
50IV Cyclophosphamide
(D00287)		1件: Cyclophosphamide2件: Cyclophosphamide (D00287),
Cyclophosphamide 💬 		--1件: 51 💬
51Lenalidomide, Dexamethasone and Cyclophosphamide
(D00287)		3件: Cyclophosphamide,
Dexamethasone,
Lenalidomide		4件: Cyclophosphamide (D00287),
Dexamethasone ,
Lenalidomide ,
Cyclophosphamide 💬 		2件: NR3C1,
TNF 💬 		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 28 💬
52Prednisone and cyclophosphamide
(D00287)		2件: Cyclophosphamide,
Prednisone		3件: Cyclophosphamide (D00287),
Prednisone ,
Cyclophosphamide 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
53Prednisone plus cyclophosphamide
(D00287)		2件: Cyclophosphamide,
Prednisone		3件: Cyclophosphamide (D00287),
Prednisone ,
Cyclophosphamide 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
54Prednisone, cyclophosphamide
(D00287)		2件: Cyclophosphamide,
Prednisone		3件: Cyclophosphamide (D00287),
Prednisone ,
Cyclophosphamide 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 40 💬
55Rituximab and Cyclophosphamide IV
(D00287)		2件: Cyclophosphamide,
Rituximab		3件: Cyclophosphamide (D00287),
Rituximab ,
Cyclophosphamide 💬 		1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 35 💬
56Rituximab, Cyclophosphamide, and Corticosteroids
(D00287)		2件: Cyclophosphamide,
Rituximab		3件: Cyclophosphamide (D00287),
Rituximab ,
Cyclophosphamide 💬 		1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
57SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD)
(D00287)		3件: Bortezomib,
Cyclophosphamide,
Dexamethasone		4件: Cyclophosphamide (D00287),
Dexamethasone ,
Bortezomib ,
Cyclophosphamide 💬 		2件: NR3C1,
PSMB5 💬 		9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28 💬
58Thalidomide, cyclophosphamide and prednisone
(D00287)		3件: Cyclophosphamide,
Prednisone,
Thalidomide		4件: Cyclophosphamide (D00287),
Prednisone ,
Thalidomide ,
Cyclophosphamide 💬 		2件: NR3C1,
TNF 💬 		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 331 💬